Insiders Legend Biotech Corporation

Stocks

LEGN

US52490G1022

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 09/06/2026 BST			After hours 01:00:00
33.49 ^USD	+6.25%		33.12	-1.10%

06-04	UBS Adjusts Legend Biotech Price Target to $49 From $31, Maintains Buy Rating	MT
06-03	Genscript Associate to Present Data for Lymphoma Drug at European Conference; Shares Surge 11%	MT

Insiders

02-06	Legend Biotech Corporation Announces Board and Audit Committee Changes, Effective February 2, 2026	CI
01-23	Legend Biotech Corporation Announces Changes to Board of Directors and Audit Committee, Effective January 20, 2026	CI
18/08/25	Legend Biotech Corporation Announces Chief Financial Officer Changes	CI
18/08/25	Legend Biotech appoints Carlos Santos as chief financial officer	RE
18/08/25	Legend Biotech Names Carlos Santos CFO	MT
18/08/25	Legend Biotech Corporation Appoints Carlos Santos as the Company?s Principal Financial Officer and Principal Accounting Officer, Each Effective as of August 18, 2025	CI
05/06/25	Legend Biotech Corporation Appoints Peter Salovey as Lead Independent Director, Effective June 5, 2025	CI
24/12/24	Legend Biotech CFO Lori Macomber to Resign, Jessie Yeung Named Interim CFO	MT
23/12/24	Legend Biotech Corporation Appoints Jessie Yeung as Interim Principal Accounting Officer, Effective January 2, 2025	CI
04/11/24	Legend Biotech Corporation Appoints Alan Bash as President of CARVYKTI®	CI
08/08/24	Legend Biotech Corporation Appoints Peter Salovey as Independent Director, Effective August 9, 2024	CI
11/03/24	Legend Biotech Corporation Announces Management Changes	CI
11/04/23	Legend Biotech Corporation Announces Appointment of Mythili Koneru, M.D., Ph.D. as Chief Medical Officer	CI
03/04/23	Legend Biotech Establishes Strategic Advisory Board	CI
17/10/22	Legend Biotech Corporation Elects Philip Yau as Director	CI
04/08/22	Legend Biotech Corporation Announces Board Changes	CI
09/05/22	Legend Biotech Names New CFO	MT
03/04/22	Legend Biotech Announces Executive Changes	CI
01/04/22	Legend Biotech Corporation Announces Appointment of Guowei Fang as Global Head of Research and Early Development	CI
30/12/21	Legend Biotech Announces Appointment of Ying Huang to the Board of Directors	CI
03/12/20	Legend Biotech Announces Appointment of Patrick Casey to the Board of Directors	CI
23/11/20	Legend Biotech Corporation Announces Board Changes	CI
09/11/20	Legend Biotech Corporation Appoints Ying Huang as Chief Executive Officer	CI
09/11/20	Legend Biotech Corporation Announces Appointment of Ye Wang as Chairwoman of the Board	CI
21/09/20	Legend Biotech Corporation Appoints Ying Huang as Interim Chief Executive Officer	CI